itraconazole has been researched along with Endometrial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, H; Hirota, S; Inoue, K; Sakane, R; Sakata, K; Shibahara, H; Sonoda, T; Tsubamoto, H | 1 |
| Inoue, K; Sakata, K; Shibahara, H; Sonoda, T; Takeyama, R; Tsubamoto, H; Ueda, T | 1 |
2 other study(ies) available for itraconazole and Endometrial Neoplasms
| Article | Year |
|---|---|
Expression of Hedgehog Signals and Growth Inhibition by Itraconazole in Endometrial Cancer.
Topics: Antineoplastic Agents; Carcinoma, Endometrioid; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Itraconazole; Signal Transduction; Time Factors; Transcription Factors; Zinc Finger Protein GLI1 | 2016 |
Itraconazole Inhibits AKT/mTOR Signaling and Proliferation in Endometrial Cancer Cells.
Topics: Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Endometrial Neoplasms; Female; Gene Expression; Humans; Itraconazole; Oncogene Protein v-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2017 |